Keith Thomas Flaherty, M.D.
This page shows the publications co-authored by Keith Flaherty and Zhenyu Ji.
Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth. Clin Cancer Res. 2013 Aug 15; 19(16):4383-91.
p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition. J Invest Dermatol. 2012 Feb; 132(2):356-64.
Targeting the RAS pathway in melanoma. Trends Mol Med. 2012 Jan; 18(1):27-35.
Molecular therapeutic approaches to melanoma. Mol Aspects Med. 2010 Apr; 31(2):194-204.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.